| EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains MC Donaldson-Collier, S Sungalee, M Zufferey, D Tavernari, ... Nature genetics 51 (3), 517-528, 2019 | 139 | 2019 |
| Conditional selection of genomic alterations dictates cancer evolution and oncogenic dependencies M Mina, F Raynaud, D Tavernari, E Battistello, S Sungalee, S Saghafinia, ... Cancer cell 32 (2), 155-168. e6, 2017 | 125 | 2017 |
| Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression D Tavernari, E Battistello, E Dheilly, AS Petruzzella, M Mina, ... Cancer discovery 11 (6), 1490-1507, 2021 | 94 | 2021 |
| Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma E Dheilly, E Battistello, N Katanayeva, S Sungalee, J Michaux, G Duns, ... Cancer cell 37 (5), 674-689. e12, 2020 | 92 | 2020 |
| Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma E Oricchio, N Katanayeva, MC Donaldson, S Sungalee, JP Pasion, ... Science translational medicine 9 (396), eaak9969, 2017 | 71 | 2017 |
| Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion E Battistello, KA Hixon, DE Comstock, CK Collings, X Chen, JR Hernaez, ... Molecular cell 83 (8), 1216-1236. e12, 2023 | 39 | 2023 |
| Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma E Battistello, N Katanayeva, E Dheilly, D Tavernari, MC Donaldson, ... Blood, The Journal of the American Society of Hematology 131 (21), 2345-2356, 2018 | 32 | 2018 |
| The stress response regulator HSF1 modulates natural killer cell anti-tumour immunity K Hockemeyer, T Sakellaropoulos, X Chen, O Ivashkiv, M Sirenko, ... Nature Cell Biology 26 (10), 1734-1744, 2024 | 1 | 2024 |
| Interrogating functional dependencies between genomic alterations can facilitate precision medicine approaches in cancer M Mina, F Raynaud, D Tavernari, E Battistello, S Sungalee, S Saghafinia, ... Annals of Oncology 28, vii2, 2017 | 1 | 2017 |
| Targeting mammalian SWI/SNF chromatin remodeling complexes to improve T cell-based cancer immunotherapies E Battistello, K Hixon, DE Comstock, CK Collings, X Chen, JR Hernaez, ... Cancer Research 83 (7_Supplement), 1794-1794, 2023 | | 2023 |
| Cathepsin inhibitors and uses thereof E Oricchio, E Battistello, M Santin, L Reymond | | 2021 |
| Novel therapeutic strategies targeting the B-cell receptor signaling and antigen presentation pathways in non-Hodgkin lymphoma E Battistello EPFL, 2019 | | 2019 |
| Group ID U12997 Affiliated authors Balli, Eleni E Battistello, M Bruand, P De Nittis, D Demeester, E Dheilly, J Diaz Miyar, ... | | |
| MYC Maintains Epstein–Barr Virus Latency in Burkitt Lymphoma E Dheilly, E Battistello, N Katanayeva, S Sungalee, J Michaux, G Duns | | |
| Breaking Insights MC Donaldson-Collier, S Sungalee, M Zufferey, D Tavernari, ... | | |
